EquityRoots
Pharmaceuticals
Healthcare · Pharmaceuticals · Long-term Compounder

Aurobindo Pharma Limited

AUROPHARMA·1389.5·₹80.7K Cr·Listed 19 Jul 2000
Composite
59
Mid-pack in Pharmaceuticals · Long-term Compounder
Rank8of 12
About AUROPHARMA
www.aurobindo.com
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables.
Healthcare
Company description
Founded
1986
Headquarters
Hyderabad, India
CEO / MD
Dr. Makkapati Satakarni B.E., M.B.A., Ph.D. · President of Biologics, CEO of Biologics, Vaccines and Peptid & Director
Major milestone
No record found in disclosures
What they do
Core products
formulation in form of oral solidsliquidsinjectablesvaccinesmetered dose inhalersand APIs
Target customers
Not explicitly disclosed
Global footprint
IndiaInternationalUnited StatesEurope
4 regions mentioned in disclosures
Shareholder breakup
Promoter
51.8%
DII
25.8%-1.8
FII
15.2%+1.3
Public
7.1%+0.5
Government
0.1%
As of Mar 2026241298 holders
Read full description

Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.

Sourced from public company disclosures.
About
Aurobindo Pharma Limited
IndustryPharmaceuticals & Biotechnology
SectorHealthcare
ClusterPharmaceuticals · Long-term Compounder
Market cap₹80.7K Cr
Listed19 Jul 2000
Price history30 years available
Fundamentals10 years available
Price history
AUROPHARMA · monthly close, 1996–2026
+34941%
21.3% CAGR · 30y
1,488.2+268.98 (+22.06%)1Y